Guilin Pharmaceutical - B (01672.HK) spent 1.9288 million Hong Kong dollars on repurchasing 200,000 shares on June 26th.

China Fortune Financial News APP reported that Gelion Pharmaceuticals-B (01672.HK) announced on June 26, 2026, that the company will spend 1.9288 million Hong Kong dollars to repurchase 200,000 shares.